The 60-Day Overpayment Rule: Identification, Quantification, and Repayment

A Medicare overpayment becomes a legal problem on the date it is identified, not on the date a pharmacy or physician practice actually receives it. Under the 60-day rule codified at 42 U.S.C. § 1320a-7k(d), a provider that fails to report and return an identified overpayment within 60 days can face liability under the False Claims Act's reverse false claims provision, treble damages, and per-claim penalties, even where the original billing error was inadvertent. A CMS final rule effective January 1, 2025 rewrote the legal test for identification, raising the stakes for every compliance officer running a self-audit.

When an Overpayment Is Legally Identified

The statute requires a provider that has received a Medicare overpayment to report and return it by the later of 60 days after the overpayment was identified, or the date any corresponding cost report is due. The Southern District of New York was the first court to interpret identified, holding in Kane v. Healthfirst, Inc. (2015) that identification occurs when a provider is put on notice of a potential overpayment, not when the amount is conclusively ascertained. CMS's original 2016 final rule (81 Fed. Reg. 7654) then set a reasonable diligence standard at 42 CFR 401.305: a provider identifies an overpayment when it has, or should have through reasonable diligence, determined it received one and quantified the amount.

CMS's 2025 Rule Replaces Reasonable Diligence With a Knowing Standard

A final rule CMS published in the Federal Register on December 9, 2024, effective January 1, 2025, eliminated the reasonable diligence standard. A provider, Medicare Advantage organization, or Part D sponsor now identifies an overpayment when it knowingly receives or retains it, borrowing the False Claims Act's definition of knowingly at 31 U.S.C. § 3729(b)(1)(A): actual knowledge, deliberate ignorance, or reckless disregard. The revised standard applies uniformly across Medicare Parts A, B, C, and D. The same rule added an express provision letting the 60-day clock pause for up to 180 days while a provider conducts a timely, good-faith investigation into whether related overpayments share the same cause.

An investigation that is not timely, not conducted in good faith, or never actually undertaken does not pause the clock, and every day of delay becomes exposure under the reverse false claims provision.

Documented Diligence During the Repayment Window

CMS makes the 180-day suspension available only to a provider that can show the investigation began promptly, covered the full universe of claims that could share the same root cause, and was actually completed rather than left open indefinitely. In practice, that means dated investigation logs, a documented root-cause analysis, a defined claims population and sampling methodology for quantification, and a record of when counsel became involved. Reckless disregard or deliberate ignorance is enough to trigger reverse false claims liability under 31 U.S.C. § 3729(a)(1)(G); the government does not need to prove actual knowledge. If the overpayment is not returned voluntarily, CMS recovers it anyway, typically through a recoupment against future claims payments, but by then the provider has forfeited the rule's safe harbor.

The same exposure arises when a relator files a sealed qui tam suit over an unreturned overpayment before the provider learns the government is involved; see How a Qui Tam Lawsuit Unfolds: From Sealed Complaint to Intervention. Liability turns on the knowing failure to repay rather than the identification itself, with the materiality limits and per-claim penalty exposure addressed in The Materiality Defense After Escobar and False Claims Act Damages and Per-Claim Penalties.

Why Early Legal Counsel Is Critical

It is critical that healthcare providers and compliance officers promptly retain healthcare defense counsel upon discovering a potential Medicare or Medicaid overpayment, or upon receiving a payer audit notice or other government inquiry touching the 60-day rule. Early legal intervention can protect the provider's rights, help ensure the investigation and quantification process meets the timely, good-faith standard the regulation requires, avoid inadvertent admissions before the scope of the issue is understood, preserve relevant defenses, and allow counsel to communicate with CMS, a Medicare Administrative Contractor, or the Department of Justice on the provider's behalf. Delaying representation can significantly affect the outcome of a matter.

How Health Law Alliance Can Help

Health Law Alliance represents pharmacies, physician practices, and healthcare companies through the identification, quantification, and repayment of Medicare and Medicaid overpayments, and defends providers when a delayed repayment becomes the basis for a False Claims Act investigation or qui tam suit. We help clients build the contemporaneous record of investigation logs, root-cause analysis, and quantification methodology that a good-faith investigation requires, and we communicate with CMS, Medicare Administrative Contractors, and DOJ on the client's behalf once a matter is underway. If your organization has identified a potential overpayment, contact us for a free, confidential consultation.